|
|
|
 |
| Location: Home -
Products - API Intermediates - API Intermediates
|
Rivaroxaban (BAY59-7939)
| Catalogue No. : |
C14113 |
| Product Name: |
Rivaroxaban (BAY59-7939) |
| Synonym: |
BAY 59-7939 |
| Chemical Name: |
5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
| CAS No. : |
366789-02-8 |
| Structure : |
|
| Molecular Formula: |
C19H18ClN3O5S |
| Molecular Weight: |
435.88 |
| Appearance: |
White solid |
| Purity: |
>99% |
| Usage: |
A novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. Rivaroxaban inhibits clot-associated,free FXa activity,and prothrombinase activity, in addition, it reduces thrombin generation. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
